VetMed Therapeutics, Inc. is a veterinary products company founded for the purpose of developing and commercializing patented, FDA-approved drug interventions for musculoskeletal diseases of the horse (and subsequently other species). Our patent-protected lead product, Equinox-PT®, is a botulinum toxin currently in development for the treatment of laminitis, a well-characterized common, painful and potentially fatal disease in horses.